USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis

NYSE:USNA • US90328M1071

20.9 USD
-0.06 (-0.29%)
At close: Feb 13, 2026
20.9 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, USNA scores 5 out of 10 in our fundamental rating. USNA was compared to 36 industry peers in the Personal Care Products industry. USNA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. USNA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • USNA had positive earnings in the past year.
  • USNA had a positive operating cash flow in the past year.
  • In the past 5 years USNA has always been profitable.
  • In the past 5 years USNA always reported a positive cash flow from operatings.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • The Return On Assets of USNA (2.34%) is comparable to the rest of the industry.
  • With a decent Return On Equity value of 3.22%, USNA is doing good in the industry, outperforming 63.89% of the companies in the same industry.
  • USNA's Return On Invested Capital of 4.04% is in line compared to the rest of the industry. USNA outperforms 52.78% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for USNA is in line with the industry average of 11.55%.
  • The last Return On Invested Capital (4.04%) for USNA is well below the 3 year average (10.32%), which needs to be investigated, but indicates that USNA had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROIC 4.04%
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • USNA's Profit Margin of 1.86% is in line compared to the rest of the industry. USNA outperforms 58.33% of its industry peers.
  • USNA's Profit Margin has declined in the last couple of years.
  • USNA has a Operating Margin (4.58%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of USNA has declined.
  • USNA's Gross Margin of 79.18% is amongst the best of the industry. USNA outperforms 94.44% of its industry peers.
  • USNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
  • USNA has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, USNA has less shares outstanding
  • USNA has a worse debt/assets ratio than last year.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • USNA has an Altman-Z score of 3.74. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
  • USNA has a better Altman-Z score (3.74) than 80.56% of its industry peers.
  • There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.74
ROIC/WACC0.48
WACC8.43%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • USNA has a Current Ratio of 2.23. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of USNA (2.23) is comparable to the rest of the industry.
  • USNA has a Quick Ratio of 1.46. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
  • USNA's Quick ratio of 1.46 is in line compared to the rest of the industry. USNA outperforms 58.33% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.46
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.74%.
  • Measured over the past years, USNA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.07% on average per year.
  • The Revenue has been growing slightly by 5.88% in the past year.
  • USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.23% yearly.
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%

3.2 Future

  • Based on estimates for the next years, USNA will show a small growth in Earnings Per Share. The EPS will grow by 3.30% on average per year.
  • USNA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.09% yearly.
EPS Next Y-31.74%
EPS Next 2Y-12.54%
EPS Next 3Y3.3%
EPS Next 5YN/A
Revenue Next Year8.86%
Revenue Next 2Y6.08%
Revenue Next 3Y6.09%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.66, which indicates a very decent valuation of USNA.
  • Based on the Price/Earnings ratio, USNA is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 27.19. USNA is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 10.51, which indicates a very decent valuation of USNA.
  • USNA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. USNA is cheaper than 77.78% of the companies in the same industry.
  • USNA is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.66
Fwd PE 10.51
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaper than 91.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.7
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The decent profitability rating of USNA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-12.54%
EPS Next 3Y3.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • USNA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USANA HEALTH SCIENCES INC

NYSE:USNA (2/13/2026, 8:04:00 PM)

After market: 20.9 0 (0%)

20.9

-0.06 (-0.29%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)10-09
Earnings (Next)02-17
Inst Owners61.98%
Inst Owner Change-4.39%
Ins Owners0.6%
Ins Owner Change0.38%
Market Cap382.05M
Revenue(TTM)912.67M
Net Income(TTM)16.99M
Analysts43.33
Price Target39.78 (90.33%)
Short Float %4.62%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-48.47%
Min EPS beat(2)-131.29%
Max EPS beat(2)34.35%
EPS beat(4)3
Avg EPS beat(4)-16.63%
Min EPS beat(4)-131.29%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)1.98%
EPS beat(12)9
Avg EPS beat(12)11.42%
EPS beat(16)9
Avg EPS beat(16)5.45%
Revenue beat(2)1
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.55%
Revenue beat(12)7
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)-1.17%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.5%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)0.58%
EPS NY rev (3m)0.58%
Revenue NQ rev (1m)2.34%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)0.56%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE 10.66
Fwd PE 10.51
P/S 0.42
P/FCF N/A
P/OCF 12.12
P/B 0.72
P/tB 1.56
EV/EBITDA 3.7
EPS(TTM)1.96
EY9.38%
EPS(NY)1.99
Fwd EY9.52%
FCF(TTM)-10.1
FCFYN/A
OCF(TTM)1.72
OCFY8.25%
SpS49.93
BVpS28.89
TBVpS13.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number35.69
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 3.22%
ROCE 6.88%
ROIC 4.04%
ROICexc 5.3%
ROICexgc 13.62%
OM 4.58%
PM (TTM) 1.86%
GM 79.18%
FCFM N/A
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexgc growth 3Y-27.3%
ROICexgc growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 973.94%
Cap/Sales 23.69%
Interest Coverage 62.89
Cash Conversion 49.24%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.46
Altman-Z 3.74
F-Score5
WACC8.43%
ROIC/WACC0.48
Cap/Depr(3y)569.36%
Cap/Depr(5y)383.35%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.74%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%-126.79%
EPS Next Y-31.74%
EPS Next 2Y-12.54%
EPS Next 3Y3.3%
EPS Next 5YN/A
Revenue 1Y (TTM)5.88%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%6.88%
Revenue Next Year8.86%
Revenue Next 2Y6.08%
Revenue Next 3Y6.09%
Revenue Next 5YN/A
EBIT growth 1Y-49.2%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year37.8%
EBIT Next 3Y22.6%
EBIT Next 5YN/A
FCF growth 1Y-347.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.96%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%

USANA HEALTH SCIENCES INC / USNA FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 5 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 5 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Fairly Valued.


Can you provide the profitability details for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.


What is the financial health of USANA HEALTH SCIENCES INC (USNA) stock?

The financial health rating of USANA HEALTH SCIENCES INC (USNA) is 8 / 10.


Can you provide the expected EPS growth for USNA stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to decline by -31.74% in the next year.